Six class action lawsuits have been filed against L’Oréal, the parent company of CeraVe, over allegations that popular acne products containing benzoyl peroxide are degrading into benzene—a known carcinogen. The lawsuits contend that L’Oréal failed to warn consumers that the active ingredient in these acne treatments can break down into benzene when exposed to common storage and temperature conditions.
This is not an allegation that benzene was intentionally added to CeraVe formulations, but rather that the company knew or should have known about a chemical transformation that occurs during normal use and storage. The litigation centers on a critical question: should manufacturers inform consumers about potentially harmful degradation products that emerge from their active ingredients, even if those products result from chemical breakdown rather than deliberate inclusion? The lawsuits were consolidated and transferred to the U.S. District Court for the Southern District of New York by May 2025, and as of June 2026, the cases remain ongoing with no final ruling issued.
Table of Contents
- What Are the CeraVe Benzene Lawsuits Alleging?
- What Did Independent Testing Reveal About Benzene in CeraVe?
- How Did the FDA Respond to Benzene Contamination Concerns?
- What Should Consumers Know About CeraVe Products and Benzene?
- Why Does Benzoyl Peroxide Degrade Into Benzene?
- Where Do the CeraVe Lawsuits Stand Now?
- Are Other Acne Products Affected by Benzene Contamination?
- Frequently Asked Questions
What Are the CeraVe Benzene Lawsuits Alleging?
The core claim in all six consolidated lawsuits is that L’Oréal knew or should have known that benzoyl peroxide—a widely used acne-fighting ingredient in CeraVe products—degrades into benzene when exposed to heat and certain storage conditions. Rather than warning consumers about this risk, the company allegedly continued to market and sell these products without disclosure. Benzene is classified as a Group 1 carcinogen by the International Agency for Research on Cancer, making the presence of even small amounts a matter of consumer concern.
The plaintiffs argue this constitutes a breach of consumer protection laws and represents a failure to provide adequate warnings about a known hazard. The lawsuits seek damages for consumers who purchased CeraVe acne products without knowing about the potential benzene contamination that could result from degradation. The legal theory hinges on the company’s duty to inform consumers about risks associated with how their products perform under normal conditions.
What Did Independent Testing Reveal About Benzene in CeraVe?
Independent laboratory testing by Valisure, a third-party testing company, identified benzene levels of 5 to 12 parts per million (ppm) in certain CeraVe products—levels that exceeded the FDA’s safety limit of 2 ppm by as much as six times. This testing was instrumental in bringing the contamination issue to public attention and served as evidence in the subsequent lawsuits. The Valisure findings demonstrated that the degradation of benzoyl peroxide into benzene was not a theoretical concern but an actual measurable problem in commercial products.
However, it’s important to note that Valisure’s testing was limited in scope compared to the broader industry-wide assessment that followed. The company tested specific batches of CeraVe products and found contamination in some but not all samples, suggesting that contamination levels may vary depending on formulation, manufacturing conditions, or storage history. This variability underscores a critical limitation: not every CeraVe product with benzoyl peroxide necessarily contains elevated benzene levels, and consumers cannot easily determine which products are affected without professional laboratory analysis.
How Did the FDA Respond to Benzene Contamination Concerns?
The FDA took action by conducting broad testing of acne products containing benzoyl peroxide across the entire industry. In 2025, the agency tested 95 acne products and found that more than 90% had either undetectable or extremely low benzene levels—suggesting that widespread contamination across all products was not occurring. This finding raised questions about the scope and severity of the problem, even as the agency acknowledged that some products did contain elevated levels.
Six products across the industry were found to have elevated benzene levels, and manufacturers initiated voluntary recalls for those products. Notably, CeraVe products were not included on the FDA’s official recall list, which some interpreted as a sign that the most widely available CeraVe formulations passed safety testing. However, this detail did not stop the lawsuits from proceeding, as plaintiffs argued that the presence of any elevated benzene levels—even in a subset of products—represented a failure to warn consumers about a known degradation risk. The distinction between what the FDA tested and found versus what independent labs detected became a point of contention in the litigation.
What Should Consumers Know About CeraVe Products and Benzene?
Consumers who have used or currently use CeraVe acne products face an uncertain situation. While the FDA’s broad testing suggests that most products contain safe levels of benzene, the independent findings from Valisure demonstrated that some batches exceeded safety limits. The practical challenge is that individual consumers have no way to know whether a particular bottle or tube of CeraVe acne product contains elevated benzene levels without sending it to a laboratory for testing—an option that is neither convenient nor typically accessible.
For those concerned about potential exposure, several options exist: discontinuing use of CeraVe products in favor of alternatives, consulting with a dermatologist about which acne treatments are safe, or monitoring ongoing litigation updates to understand the scope of contamination. Some consumers may also consider preserving product receipts and packaging in case they wish to join the class action lawsuits or file claims if a settlement is reached. The trade-off is that discontinuing benzoyl peroxide products may require switching to alternative acne treatments with different efficacy profiles or side effects.
Why Does Benzoyl Peroxide Degrade Into Benzene?
Benzoyl peroxide is an organic compound that can decompose when exposed to heat, moisture, or UV light. Under these conditions—which are common during storage in bathrooms, sun-exposed shelves, or warm climates—the chemical structure of benzoyl peroxide breaks down, and one of the resulting byproducts is benzene. This degradation pathway is not new to chemistry; it has been documented in scientific literature for years.
The critical issue in the lawsuits is not that degradation occurs—this is a known chemical phenomenon—but whether manufacturers had a responsibility to warn consumers about it and whether they should have formulated products or recommended storage conditions that would minimize this breakdown. A major limitation of the current debate is that consumers typically do not store products under ideal conditions; bathrooms are humid, temperatures fluctuate, and products may sit on shelves for extended periods. The lawsuits argue that L’Oréal should have anticipated these real-world conditions and either prevented degradation through better formulation or provided explicit storage guidance and warnings.
Where Do the CeraVe Lawsuits Stand Now?
As of June 2026, all six class action lawsuits remain consolidated in the U.S. District Court for the Southern District of New York, where they were transferred in May 2025. No final ruling has been issued, and the cases continue to proceed through the litigation process.
At this stage, the cases are likely in discovery or pre-trial motions, which means attorneys for both sides are gathering evidence and presenting legal arguments about the viability of the claims. The timeline for resolution is uncertain. Class action lawsuits can take years to reach settlement or trial, and this case involves complex questions about product liability, manufacturer duty to warn, and whether degradation products constitute a material defect. Consumers who believe they were harmed may still have time to join the class, depending on filing deadlines and how their state’s laws define the statute of limitations.
Are Other Acne Products Affected by Benzene Contamination?
The benzene contamination issue extends beyond CeraVe. The FDA’s testing of 95 acne products revealed that six products across the industry showed elevated benzene levels, and those manufacturers initiated voluntary recalls. While CeraVe products were notably absent from the recall list, this does not mean the company’s products are entirely unaffected—it reflects the results of the FDA’s particular testing protocol and sample selection.
Other benzoyl peroxide acne products from different manufacturers have also faced similar scrutiny and recalls. This broader contamination pattern suggests that benzene formation from benzoyl peroxide degradation is a systemic issue affecting acne treatments across the industry, not a problem unique to CeraVe or L’Oréal. Consumers using any benzoyl peroxide-based acne product should be aware of this risk and consider how they store these products. Keeping benzoyl peroxide products in cool, dry places away from direct sunlight may help minimize degradation, though the lawsuits suggest that manufacturers should bear responsibility for ensuring their products remain safe even under normal use and storage conditions.
- —
Frequently Asked Questions
Are all CeraVe acne products contaminated with benzene?
No. The FDA tested 95 acne products in 2025 and found that more than 90% had undetectable or extremely low benzene levels. Valisure, an independent lab, did detect elevated benzene in some CeraVe samples, but CeraVe products were not on the FDA’s official recall list. Contamination appears inconsistent across different batches and formulations.
What is the FDA’s benzene limit for acne products?
The FDA’s safety limit for benzene is 2 parts per million (ppm). Independent testing found some CeraVe products contained 5 to 12 ppm, exceeding this limit by up to six times.
Can I still use my CeraVe acne products safely?
This depends on your comfort level with the risk and which specific products you use. Since most products tested had safe benzene levels but some did not, individual risk varies. Consulting a dermatologist about alternative acne treatments is an option, as is careful storage in cool, dry conditions.
How long will the lawsuits take to resolve?
Class action lawsuits typically take years to reach settlement or trial. As of June 2026, no final ruling has been issued. Consumers may still be able to join the consolidated case if deadlines allow.
Is benzoyl peroxide itself unsafe?
Benzoyl peroxide is an FDA-approved acne ingredient with a long history of safe use. The issue in these lawsuits is not the ingredient itself but the degradation byproduct—benzene—that can form under normal storage conditions.
Are other acne brands affected by benzene contamination?
Yes. The FDA identified six acne products across the industry with elevated benzene levels, and those manufacturers initiated voluntary recalls. The issue is not unique to CeraVe but appears to affect benzoyl peroxide-based products more broadly. —
